Ascentage Pharma Group International (AAPG) Accumulated Expenses (2023 - 2026)

Ascentage Pharma Group International's Accumulated Expenses history runs 3 years deep, the most recent figure standing at $381949.0 for Q4 2025.

• In Q4 2025, Accumulated Expenses fell 81.52% year-over-year to $381949.0; the TTM figure through Dec 2025 stood at $381949.0 (down 81.52% YoY), while the FY2025 annual figure was $387000.0, down 80.97% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $381949.0, down from $34.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $34.8 million in Q2 2025, with the low at $381949.0 in Q4 2025.
• The 3-year median for Accumulated Expenses is $1.3 million (2023), against an average of $9.5 million.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses surged 263.87% in 2024, then plunged 81.52% in 2025.
• Ascentage Pharma Group International's Accumulated Expenses stood at $568049.4 in 2023, then soared by 263.87% to $2.1 million in 2024, then slumped by 81.52% to $381949.0 in 2025.
• Business Quant data shows AAPG's Accumulated Expenses at $381949.0 in Q4 2025, $34.8 million in Q2 2025, and $2.1 million in Q4 2024.